Bioregenx (BRGX) Income from Continuing Operations (2022 - 2026)
Bioregenx's quarterly Income from Continuing Operations came in at 126850.0 in Q1 2026, up 52.46% year-on-year from 83199.62 in Q1 2025, and up 87.54% quarter-over-quarter from 1017805.0 in Q4 2025.
Bioregenx has reported Income from Continuing Operations for 5 years, with the latest figure at 126850.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 52.46% year-over-year to 126850.0; the trailing twelve-month figure through Mar 2026 stood at 1403565.0 (up 93.04% YoY), and the FY2025 full-year result was 1543569.0, up 93.3% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 126850.0, up from 1017805.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2191.0 in Q3 2022, with the low at 18400571.0 in Q4 2024.
- Average Income from Continuing Operations over 5 years is 1371336.18, with a median of 178345.0 recorded in 2025.
- Year-over-year, Income from Continuing Operations slumped 26695.74% in 2024 and jumped 94.47% in 2025.
- Tracing BRGX's Income from Continuing Operations over 5 years: stood at 5535.0 in 2022, then sank by 12907.52% to 719966.0 in 2023, then tumbled by 2455.76% to 18400571.0 in 2024, then jumped by 94.47% to 1017805.0 in 2025, then soared by 87.54% to 126850.0 in 2026.
- The last three Income from Continuing Operations figures came in at 126850.0 (Q1 2026), 1017805.0 (Q4 2025), and 80565.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 244.20 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 35.13 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 19.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 43.32 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -13.47 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -126,850.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,850.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -80,565.00 |
| Jun 30, 2025 | -178,345.00 |
| Mar 31, 2025 | -266,854.00 |
| Dec 31, 2024 | -18.40 Mn |
| Sep 30, 2024 | -394,860.00 |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -704,806.00 |
| Dec 31, 2023 | -719,966.00 |
| Sep 30, 2023 | -3,691.00 |
| Jun 30, 2023 | -4,128.00 |
| Mar 31, 2023 | -229,838.00 |
| Dec 31, 2022 | -5,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |